News, Page 3
March 23, 2022
Multicolumn Countercurrent Solvent Gradient Purification Process To Be Discussed By YMC at the World Biopharma Forum 2022
History shows that uptake of innovation is metered in the biopharma industry, but if the invention has checked all the “user need” boxes, its acceptance has an inflection point. This inflection point, when graphed, resembles a hockey stick (hopefully pointing
January 15, 2022
YMC’s BioPro is a Reliable Tool for Analyzing PEGylated Proteins
Ligand® Pharmaceuticals Inc. had an excellent success utilizing YMC’s BioProIEX to analyze PEGylated protein charge variants reproducibly. They developed a characterization method for PEGylated biotherapeutic proteins that can provide increased information without compromising peak shape and resolution and wanted to
August 24, 2021
YMC Launches New Laboratories
YMC has significantly expanded its lab capabilities in the USA by opening labs in Devens, MA and Thousand Oaks, CA (USA) to complement their long-standing partner lab in Maryland. Much more than testing or demo labs, YMC will be using
July 12, 2021
We’re Making Moves To Serve You Better
YMC America just completed the combination and expansion of our US operations at our YMC campus in Devens, MA. This puts our columns and stationary phase team under the same roof (actually, several roofs) with the research, design, and manufacturing
June 22, 2021
YMC Scale Up Platform Product Array
YMC illustrates the complete portfolio of consumables and systems that synergize to aid scale-up from lab to production. Learn More. More Information on InformaConnect
June 22, 2021
YMC Completes Phase 1 of Growth Plan in America
YMC America has completed the successful co-location and expansion of its US business operations at its growing campus in Devens, MA. The purpose of the move was to consolidate operations in a single facilities center, while also adding much-needed expansion
April 29, 2021
YMC 5 Year Vision
YMC’s Corporate Vision was recently articulated by YMC President Ryuji Yamamura, and published in an issue of Newsweek International. In the article, Mr. Yamamura points out that, “… the greatest strength of YMC’s business model is that we are uniquely
March 4, 2021
Large scale production of peptide program announced
PeptiDream and YMC groups announce a formal joint-task group to scale successful lab work to multiple GMP production lines for specialty peptide drug products at the main factory of PeptiStar Inc. Learn More.
February 9, 2021
Webinar on Continuous Countercurrent Chromatography
Twin-column continuous countercurrent chromatography is an excellent technique for achieving high yield and high purity in the manufacturing scale purification of peptide and oligo therapeutics.
February 8, 2021
Do You Have Questions About YMC America’s Move to Devens, MA?
As we announced in early January, effective February 1, YMC America business operations have relocated to Devens, MA. This move will enable us to add resources, space, and expanded services for our customers. We invite you to read more about
January 11, 2021
YMC expands, consolidates operations in America
YMC plans expansion of lab development services and consolidation of its Allentown, PA location into its larger Devens, MA facility. Learn More.
January 6, 2021
YMC America Business Operations to Relocate to Devens, MA
YMC America business operations will relocate to Devens, MA, to add resources, space, and improved access to the epicenter of the global bio/pharma industry.
